Product Program year 2021 Source: CMS Open Payments

Andexxa

Drug Hematology

NDC 69853-0102-1

Open in the dashboard

General payments

$984,362

3,809 payments

Research payments

$0

0 payments

Through program year 2021, $984,362 in general payments and $0 in research payments were reported against Andexxa (Hematology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2021 General $984,338 3,808
2020 General $24 1

Breakdown

Who paid General payments · program years 2020–2021
  1. Alexion Pharmaceuticals, Inc. $984,362 3,809 payments
Top recipients General payments · program year 2021
  1. Rondel Albarado Surgical Critical Care · Houston, TX $53,576 5% · 52 payments
  2. Niels Martin Trauma Surgery · Philadelphia, PA $51,380 5% · 46 payments
  3. Fariborz Rezai Critical Care Medicine · Livingston, NJ $47,311 5% · 64 payments
  4. James Williams Emergency Medicine · San Antonio, TX $40,448 4% · 46 payments
  5. Nirav Patel Neurology · Los Alamitos, CA $39,637 4% · 42 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2021
  1. Emergency Medicine $240,569 27% · 426 practitioners
  2. Neurology Psychiatry & Neurology $110,387 12% · 135 practitioners
  3. Surgical Critical Care Surgery $78,004 9% · 23 practitioners
  4. Trauma Surgery Surgery $64,904 7% · 24 practitioners
  5. Critical Care Medicine Internal Medicine $63,426 7% · 33 practitioners

The top 5 of 108 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2021
  1. California $136,227 14% · 122 recipients
  2. Florida $122,577 12% · 353 recipients
  3. Texas $118,214 12% · 309 recipients
  4. New Jersey $85,181 9% · 157 recipients
  5. Pennsylvania $76,849 8% · 47 recipients

The top 5 of 48 states; each share is of general payments naming this product in 2021 where a state was reported.

The top 25 states, free in the app

3,809 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2021

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record